https://www.news-medical.net/news/20220908/Biosynthetic-proteins-show-promise-as-SARS-CoV-2-antivirals-targeting-spike-protein.aspx
Researchers developed an αRep series specific to the RBD of the SARS-CoV-2 S, which could easily adapt to work stably against SARS-CoV-2 variants at a low cost.
Create an account or login to join the discussion